Sartorius | SRT3 - Cost Of Sales


Sartorius reported EUR478.7M in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Avita Medical AUD 3.3M 166K Dec/2025
Ionis Pharmaceuticals USD 2.74M 261K Jun/2026
IQVIA Holdings USD 3.22B 141M Jun/2026
Moderna USD 93M 862M Jun/2026
Organon & Co USD 677M 89M Mar/2026
Revvity USD 312.82M 10.64M Jun/2026
Sartorius EUR 478.7M 5.9M Jun/2026
Viatris USD 2.3B 59.5M Jun/2026
Xeris Pharmaceuticals USD 10.57M 3.08M Mar/2026